Short interest in GlycoMimetics Inc (NASDAQ:GLYC) decreased during the last reporting period, falling from 2.58M to 2.46M. This put 4.62% of the company's publicly available shares short.

GlycoMimetics, Inc. (NASDAQ:GLYC) shares are moving higher on Tuesday after the company announced it will merge with Crescent Biopharma. The company also said it secured $200 million in funding to ...

GLYCOMIMETICS ($GLYC) is expected to release its quarterly earnings data on Tuesday, March 25th after market close, per Finnhub. Analysts are expecting revenue of $0 ...

In light of current market conditions, we explore three... GlycoMimetics ( (GLYC) ) has shared an update. GlycoMimetics and Crescent Biopharma have updated their investor presentation related to ...

NASDAQ GLYC opened at $0.27 on Friday. GlycoMimetics has a 52-week low of $0.14 and a 52-week high of $3.18. The company has a fifty day moving average of $0.27 and a 200-day moving average of $0. ...

Investment analysts at StockNews.com initiated coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Free Report) in a report issued on Monday. The firm set a “sell” rating on the biotechnology ...

Fintel reports that on March 21, 2025, Cantor Fitzgerald initiated coverage of GlycoMimetics (NasdaqCM:GLYC) with a Overweight recommendation. Analyst Price Forecast Suggests 294.89% Upside As of ...

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide ...